The first noticeable effect is usually a decrease in appetite and an increased feeling of fullness, which helps patients adhere better to their dietary plans and achieve compounding benefits
In comparison with other common peptides like GHRP-6 and Ipamorelin, AOD 9604 uniquely does not impact insulin levels while actively promoting fat loss and preventing fat accumulation
Growth hormone, in turn, increases the production of insulin-like growth factor-1 (IGF-1)
Because these medications reduce appetite and therefore food intake, in the research were seeing people experience nutrient deficiencies, muscle loss, and reduced bone density - especially with rapid weight loss
While mild at first, continued nausea indicates worsening toxicity, requiring emergency care to prevent progression to liver damage
I like many others on the forum now self inject